Figure 2.

Leukemia PDX models show variability in time to engraftment and cell surface markers

(A) Number of total leukemia samples collected for PDX collection by subtype detailing engraftment (black) versus no engraftment (gray) after implantation.

(B) Percentage of engraftment samples for each leukemia subtype.

(C) Engraftment rates of leukemia subtypes.

(D) Percentage of maintained cell surface markers on the primary leukemia with its paired patient derived xenograft. Total number of paired samples analyzed for that particular cell surface marker noted later in discussion.